Treatment of acquired reactive perforating collagenosis with dupilumab in a patient with end-stage renal disease.

Dermatol Ther

Department of Dermatology, Nowon Eulji Medical Center, Eulji University, Seoul, Republic of Korea.

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1111/dth.15926DOI Listing

Publication Analysis

Top Keywords

treatment acquired
4
acquired reactive
4
reactive perforating
4
perforating collagenosis
4
collagenosis dupilumab
4
dupilumab patient
4
patient end-stage
4
end-stage renal
4
renal disease
4
treatment
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!